Topics

Origenis GmbH Company Profile

02:12 EST 24th January 2020 | BioPortfolio

Origenis GmbH is a privately-held German biopharmaceutical company developing brain-penetrating highly selective small molecule medicines and diagnostics for a variety of neurodegenerative and neuroinflammatory diseases. Origenis leverages its unique capabilities in drug design, compound synthesis and characterization to engineer a continuous stream of proprietary IP-protected new chemical entities capable of permeating the blood-brain barrier. Origenis’ approach has been validated by multiple partners resulting in a significant IP and R&D portfolio that ensures strong patent protection. For more information, visit www.origenis.com.


News Articles [156 Associated News Articles listed on BioPortfolio]

Origenis GmbH Announces Research Collaboration with U.S. Cancer Center

- Origenis AI Discovery Platform to Identify and Optimize Small Molecule Preclinical Development Candidates for Glioblastoma - Origenis GmbH, a privately-held German biopharma...

Marinomed-Aktionäre platzieren bis zu 105.000 Aktien

Bei Marinomed kommt er erneut zu einem Aktienverkauf. Die Gesellschaften Acropora Beteiligungs GmbH, VETWIDI Forschungsholding GmbH und BVT Beteiligungsverwaltung und Treuhand GmbH bieten im Wege e...

Marinomed-Aktien erneut zu 95,0 Euro platziert

Die Marinomed-Aktionäre Acropora Beteiligungs GmbH, VETWIDI Forschungsholding GmbH und BVT Beteiligungsverwaltung und Treuhand GmbH haben im Wege eines Accelerated Bookbuildings ins Summe 105.000 A.....

Osteolabs GmbH receives major contract

osteolabs GmbH announced the successful closing of its first commercial agreements for Germany and Turkey. For Germany, the company has signed up with Eurofins LifeCodexx GmbH as exclusive partner in ...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Marinomed Biotech: Aktionäre platzieren Anteile

Drei Großaktionäre von Marinomed Biotech wollen Aktien des Unternehmens platzieren: Acropora Beteiligungs GmbH, VETWIDI Forschungsholding GmbH und BVT Beteiligungsverwaltung und Treuhand GmbH haben....

Laufende Fusionskontrollverfahren: Capgemini Deutschland GmbH, Berlin; Erwerb von Vermögensteilen der Bayer Business Services GmbH, Leverkusen

Datum der Anmeldung:11.12.2019Aktenzeichen:B7-253/19Unternehmen:Capgemini Deutschland GmbH, Berlin; Erwerb von Vermögensteilen der Bayer Business Services GmbH, LeverkusenProduktmärkte:IT-Dienstlei....

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

Drugs and Medications [15 Associated Drugs and Medications listed on BioPortfolio]

La prairie switzerland [juvena produits de beaute gmbh]

Package.Label Principle Display Panel

Tobramycin [holopack verpackungstechnik gmbh]

Tobramycin Inhalation Solution (300 mg/5 mL)

Lonhala [holopack verpackungstechnik gmbh]

Glycopyrrolate Inhalation Solution (25 µg/mL)

Etoposide [thymoorgan gmbh pharmazir & co. k.g]

Etoposide Injection, USP

Oxygen [metro aire ltd]

Oxygen

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Varifocal Versus Monofocal LASIK in Presbyopic Hyperopic Eyes.

To compare varifocal (SupraCor; Technolas Perfect Vision GmbH, Munich, Germany) to monofocal (Zyoptix TissueSaving; Bausch & Lomb, Rochester, NY) LASIK in patients with hyperopic presbyopia.

Immediate and short term visual recovery after SmartSurf photorefractive keratectomy.

To investigate immediate and short-term visual recovery in a large cohort of 2093 myopic eyes (with or without astigmatism) treated with SmartSurf procedure, a combination of Transepithelial Photo Ref...

The performance of a new point-of-care HIV virus load technology to identify patients failing antiretroviral treatment.

A new point-of-care (POC) HIV virus load technology has been recently developed and designed to be utilized in decentralized settings. Alere Technologies GmbH*, Germany, developed the mPIMA HIV-1/2 ...

Thawing times and hemostatic assessment of fresh frozen plasma thawed at 37°C and 45°C using water-bath methods.

The Barkey Plasmatherm (BP; Barkey GmbH & Co. KG) can thaw plasma at 37°C and 45°C. No studies have assessed thawing times or hemostatic qualities of plasma thawed at 45°C with BP. This study asses...

Horseshoe kidney protection with histidine-tryptophan-ketoglutarate solution during surgical abdominal aortic aneurysm repair.

We report an unusual case of a 65-year-old male patient with horseshoe kidney, who underwent a successful open repair for abdominal aortic aneurysm. The accessory renal arteries were perfused with his...

Clinical Trials [66 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Physiological Responses at the Anterior Surface of Two (Hydrophobic Acrylic) Intraocular Lens Models

On the day of surgery, the the eye with astigmatism of at least 0.75dpt receives a Vivinex XY1A , HOYA Surgical Optics GmbH and the second eye to be operated receives an XY1, HOYA Surgical...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care Devices

This study includes patients undergoing elective cardiac surgery on MiECC. Coagulation status is assessed with ROTEM (TEM International GmbH, Munich, Germany) and Platelet function with im...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Companies [550 Associated Companies listed on BioPortfolio]

Origenis GmbH

Origenis GmbH is a privately-held German biopharmaceutical company developing brain-penetrating highly selective small molecule medicines and diagnostics for a variety of neurodeg...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "Origenis GmbH" on BioPortfolio

We have published hundreds of Origenis GmbH news stories on BioPortfolio along with dozens of Origenis GmbH Clinical Trials and PubMed Articles about Origenis GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Origenis GmbH Companies in our database. You can also find out about relevant Origenis GmbH Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record